Natalie Callander

基本信息

浏览量：27

职业迁徙

个人简介

Dr. Callander’s clinical focus is on multiple myeloma, malignant hematology, transplant and quality of life.
Dr. Callander’s current research is focusing on new therapies in all stages of multiple myeloma and the development of clinical trials.

研究兴趣

论文共 380 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Expert Perspectives on Current Challenges and Emerging Approaches for Multiple Myeloma: Narrative Review of an Inaugural Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma

Ajai Chari,Susan Bal,Sikander Ailawadhi,Amrita Krishnan, Krina K Patel,Jesus G Berdeja,Alfred Garfall,Natalie Callander,Rahul Banerjee,Melissa Alsina, Ajay K Nooka,Binod Dhakal,Cristina Gasparetto,Caitlin Costello

Clinical lymphoma, myeloma & leukemia (2025)

引用0浏览0WOS引用

Establishing Measurable Residual Disease Trajectories for Patients on Treatment for Newly Diagnosed Multiple Myeloma As Benchmark for Deployment of T-cell Redirection Therapy

Susan Bal,Tylan Magnusson,Gayathri Ravi,Smith Giri,Kelly Godby,Binod Dhakal,Natalie S Callander,Rebecca W Silbermann,Bhagirathbhai Dholaria,Vishnu B Reddy,Luciano J Costa

Blood cancer journalno. 1 (2025): 73-73

引用0浏览0WOSNATURE引用

Implications of Isolated MRD Progression in Newly Diagnosed Multiple Myeloma Treated with Quadruplet Therapy

Luciano J. Costa,Eva Medvedova,Binod Dhakal,Bhagirathbhai R. Dholaria,Kelly N. Godby,Susan Bal,Gayathri Ravi,Smith Giri,Saurabh Chhabra,Rebecca Silbermann,Natalie S. Callander

Blood Cancer Journalno. 1 (2025): 1-4

引用0浏览0WOSNATURE引用

P-164 Establishing MRD Benchmark for Deployment of T-cell Redirection As Post Induction Therapy in Newly Diagnosed Multiple Myeloma

Susan Bal,Tylan Magnusson,Gayathri Ravi,Smit Giri,Kelly Godby,Binod Dhakal,Bhagirathbhai Dholaria,Rebecca Silbermann,Natalie Callander,Vishnu Reddy,Luciano Costa

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2024): S133-S134

引用0浏览0引用

P-150 Rapid Whole-Body PET/MRI with Fat-Suppressed T2-Weighted Imaging is Superior to Whole-Body PET/MRI with Diffusion-Weighted Imaging (DWI) in Plasma Cell Disorders

Timothy Schmidt, Rianne Van der Heijden,Zhubin Gahvari,Matthew Brunner,Natalie Callander,Ali Pirasteh

Clinical Lymphoma Myeloma and Leukemia（2024）

引用0浏览0引用

Phase 1b/2 Trial of Iberdomide in Combination with Daratumumab, Dexamethasone Plus /-Carfilzomib to Eliminate MRD after Induction Therapy and ASCT in NDMM

Luciano Costa,Rebecca Silbermann,Gayathri Ravi,Zhubin Gahvari,Eva Medvedova,Bhagirathbhai Dholaria,Naresh Bumma,Doris Hansen, Everette Colquette,Pamela Hardwick,Natalie Callander

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2024): S222-S223

引用0浏览0引用

Optimal MRD-Based Endpoint in the Setting of Upfront Quadruplets (quads) to Support Response-Adapted Treatment Cessation in Newly Diagnosed Multiple Myeloma (NDMM)

Smith Giri,Binod Dhakal,Natalie Callander,Eva Medvedova,Kelly Godby,Susan Bal,Gayathri Ravi,Saurabh Chhabra,Rebecca W. Silbermann,Luciano J. Costa

Bloodno. Supplement 1 (2024): 257-257

引用0浏览0引用

Inpatient vs Outpatient Use of Teclistamab in Multiple Myeloma

Ajai Chari,Natalie Callander,Matthew James Pianko,Timothy Schmidt,C. Ola Landgren,Caitlin Costello

ONCOLOGY-NEW YORKno. 2 (2024)

引用0浏览0引用

Infective Endocarditis is Rare in Patients with Hematologic Malignancy and Neutropenia

Michael J. Scolarici,Leigh R. Berman,Natalie Callander,Jeannina Smith,Christopher Saddler

Transplant Infectious Diseaseno. 3 (2024)

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

教授

论文共 380 篇作者统计合作学者相似作者